Multiple Myeloma Continue News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Multiple Myeloma Continue. Real-time updates on events, politics, business and more.

2seventy bio Presents Data Across Multiple Cell Therapy Programs at ASH 2021 Annual Meeting

December 14, 2021

14.12.2021 - 2seventy bio, Inc. (NASDAQ: TSVT) today announced data from its broad oncology cell therapy portfolio, including updated results from the CRB-402 study of bb21217 and new analyses from the pivotal KarMMa study of ABECMA (idecabtagene vicleucel; ...

Hemophagocytic Lymphohistiocytosis European Union Bristol Myers Squibb Key Insights New Data Multiple Myeloma Continue

Source: wallstreet-online.de

2seventy bio Presents Data Across Multiple Cell Therapy Programs at ASH 2021 Annual Meeting

December 13, 2021

Press release content from Business Wire. The AP news staff was not involved in its creation.

United States United Kingdom Elizabeth Pingpank Hemophagocytic Lymphohistiocytosis Philip Gregory Bristol Myers Squibb

Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Multiple Myeloma Continue News Today

2seventy bio Presents Data Across Multiple Cell Therapy Programs at ASH 2021 Annual Meeting

2seventy bio Presents Data Across Multiple Cell Therapy Programs at ASH 2021 Annual Meeting

Explore More Categories